- Home
- MANU vs XENE Comparison
MANU vs XENE Comparison
Compare MANU & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANU
- XENE
- Stock Information
- Founded
- MANU 1878
- XENE 1996
- Country
- MANU United Kingdom
- XENE Canada
- Employees
- MANU N/A
- XENE N/A
- Industry
- MANU Services-Misc. Amusement & Recreation
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- MANU Consumer Discretionary
- XENE Health Care
- Exchange
- MANU Nasdaq
- XENE Nasdaq
- Market Cap
- MANU 2.9B
- XENE 3.0B
- IPO Year
- MANU 2012
- XENE 2014
- Fundamental
- Price
- MANU $16.96
- XENE $39.83
- Analyst Decision
- MANU Hold
- XENE Strong Buy
- Analyst Count
- MANU 1
- XENE 10
- Target Price
- MANU $18.50
- XENE $57.30
- AVG Volume (30 Days)
- MANU 258.2K
- XENE 382.6K
- Earning Date
- MANU 09-11-2024
- XENE 11-12-2024
- Dividend Yield
- MANU N/A
- XENE N/A
- EPS Growth
- MANU N/A
- XENE N/A
- EPS
- MANU N/A
- XENE N/A
- Revenue
- MANU $836,320,093.00
- XENE N/A
- Revenue This Year
- MANU $2.71
- XENE N/A
- Revenue Next Year
- MANU $8.90
- XENE $1,600.08
- P/E Ratio
- MANU N/A
- XENE N/A
- Revenue Growth
- MANU 2.06
- XENE N/A
- 52 Week Low
- MANU $13.50
- XENE $28.20
- 52 Week High
- MANU $22.00
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- MANU 51.32
- XENE 39.07
- Support Level
- MANU $15.81
- XENE $41.42
- Resistance Level
- MANU $18.12
- XENE $44.61
- Average True Range (ATR)
- MANU 0.40
- XENE 1.53
- MACD
- MANU 0.05
- XENE -0.36
- Stochastic Oscillator
- MANU 49.57
- XENE 2.99
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.